Latest Announcements

BSE & NSE corporate filings with AI summaries

BSEBoard Meeting▲ PositiveResults30 Jul 2026

Vivid Global Industries Ltd

Vivid Global Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve 1.To consider, approve ....

Vivid Global Industries Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 to consider and approve unaudited financial results for the quarter ended 30th June, 2026, along with limited review report, and other items.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults30 Jul 2026

Best Agrolife Limited

Outcome of Board Meeting

Best Agrolife Limited has announced its financial results for the quarter ended June 30, 2026, with revenue from operations growing 4% YoY to ₹396 crore, gross profit increasing 32% YoY to ₹146 crore, and profit after tax (PAT) rising 104% YoY to ₹41 crore.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults30 Jul 2026

Tata Steel Ltd

Outcome of Board Meeting

Tata Steel Ltd's Board of Directors approved the Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2026, and also approved the core project of steelmaking capacity expansion by 4.8 MTPA in NINL at an estimated capex of ₹33,873 crore.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveFundraise30 Jul 2026

Union Bank of India

Outcome of Board Meeting

Union Bank of India has informed the Exchange regarding Outcome of Board Meeting held on July 30, 2026, where the Board of Directors approved raising Foreign Currency Funds to the extent of USD 2.00 Billion through Medium Term Note Programme.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults30 Jul 2026

Vinyoflex Ltd

We enclosed here Outcome of the Board Meeting held on Thursday, 30th July 2026 for the consideration and approval of the Unaudited Financial Results for the quarter ended June 30, 2026

Vinyoflex Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 83.59 lakhs. The company's revenue from operations was Rs. 948.69 lakhs, and its expenses totaled Rs. 837.10 lakhs. The financial results have been reviewed by the Audit Committee and approved by the Board of Directors.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults30 Jul 2026

Oriental Aromatics Ltd-$

Outcome of Board Meeting held today i.e 30th July, 2026

Oriental Aromatics Ltd announced its unaudited financial results for the quarter ended 30th June 2026, with a net profit of ₹815.32 lakhs and earnings per share of ₹242. The company's revenue from operations was ₹25,670.56 lakhs, and its total income was ₹25,766.84 lakhs. The board of directors also approved the appointment of Mr. Nitin Bhuduvalekar as Vice President - Sales Fragrance, effective from 30th July 2026.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults30 Jul 2026

Jasch Gauging Technologies Ltd

Unaudited standalone financial results for the quarter ended on 30.06.2026 along with limited review report of the auditors and Interim Dividend were approved.

Jasch Gauging Technologies Ltd has announced unaudited standalone financial results for the quarter ended 30.06.2026, with revenue from operations at Rs. 1,468.24 lakh and profit from continuing operations at Rs. 368.51 lakh. The company has also declared an interim dividend of Rs. 10 per equity share.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults30 Jul 2026

Paushak Ltd

Outcome of Board Meeting

Paushak Ltd announced its unaudited financial results for the quarter ended 30th June, 2026, with a profit before tax of Rs 1,902 lakhs, a tax expense of Rs 391 lakhs, and a profit after tax of Rs 1,510 lakhs. The company's earnings per share (EPS) for the quarter was Rs 6.13.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults30 Jul 2026

Mankind Pharma Ltd

Outcome of Board Meeting

Mankind Pharma Ltd's board meeting outcome announced financial results for Q1 2026, with corporate guarantee issued in favour of Bharat Serums and Vaccines Ltd, and unaudited standalone financial results reviewed by S.R. Batliboi & Co. LLP and Bhagi Bhardwaj Gaur & Co.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults30 Jul 2026

OCCL Limited

Outcome of Board Meeting

OCCL Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, showing a profit of Rs. 4,025.09 lakhs and an earnings per equity share of Rs. 806.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults30 Jul 2026

Vedanta Limited

Outcome of Board Meeting

Vedanta Limited has submitted its unaudited consolidated and standalone financial results for the first quarter ended June 30, 2026, with the report of the auditors being unmodified.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults30 Jul 2026

OCCL Ltd

Outcome of Board Meeting

OCCL Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 21,966.94 lakhs, a 48.6% increase from the previous quarter. The company has reported a profit for the period of Rs. 4,025.09 lakhs, with earnings per equity share at Rs. 806.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults30 Jul 2026

Ajanta Pharma Limited

Outcome of Board Meeting

Ajanta Pharma Limited has announced its Q1 FY 2027 financial results, with revenue up 25% and PAT up 31% compared to Q1 FY 2026. The company has also approved an interim dividend of Rs. 32 per share, amounting to Rs. 400 cr. The company's India branded generic segment has exceeded IPM growth by 36%, driven by new launches and volumes.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults30 Jul 2026

Ajanta Pharma Ltd

Board Meeting Outcome

Ajanta Pharma Ltd reported Q1 FY 2027 results, with revenue up 25% and PAT up 31% YoY. The company declared an interim dividend of Rs. 32 per share, amounting to Rs. 400 cr. The company's India branded generic segment exceeded IPM growth by 36%.

Read more →📎 1 attachment